The forecasted healthcare expenditure on prescribed medicines in Poland as a percentage of GDP shows a decreasing trend from 2024 to 2028. The values are projected to decline year-on-year by approximately 4.2% from 2024 to 2025, 4.3% from 2025 to 2026, 2.3% from 2026 to 2027, and 4.7% from 2027 to 2028. This indicates a continuous reduction in the GDP allocation for prescribed medicines over the forecast period, with an average annual decrease (CAGR) of 3.9% from 2024 to 2028.
Future trends to watch for:
- Potential policy changes impacting healthcare funding and medicine subsidies.
- Technological advancements in pharmaceuticals that may alter expenditure patterns.
- Shifts in public health priorities and the prevalence of chronic diseases requiring long-term medication.
